Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bayerische Motoren Werke ADR (BMWYY)

Bayerische Motoren Werke ADR (BMWYY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 52,787,556
  • Shares Outstanding, K 1,807,793
  • Annual Sales, $ 168,296 M
  • Annual Income, $ 12,219 M
  • EBIT $ 18,075 M
  • EBITDA $ 27,787 M
  • 60-Month Beta 1.10
  • Price/Sales 0.31
  • Price/Cash Flow 2.31
  • Price/Book 0.52
  • Price/Earnings ttm 4.68
  • Earnings Per Share ttm 5.96
  • Most Recent Earnings $1.49 on 08/01/24
  • Next Earnings Date 03/20/25
  • Annual Dividend & Yield 1.56 (5.35%)
  • Most Recent Dividend 1.561 on 05/16/24
  • Sector Auto-Tires-Trucks
  • INDUSTRY GROUPING Auto - Foreign

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.1500 +16.10%
on 09/10/24
31.7700 -8.09%
on 08/27/24
-2.2800 (-7.24%)
since 08/26/24
3-Month
25.1500 +16.10%
on 09/10/24
33.5900 -13.07%
on 07/12/24
-2.1300 (-6.80%)
since 06/26/24
52-Week
25.1500 +16.10%
on 09/10/24
41.6500 -29.89%
on 04/04/24
-4.6600 (-13.76%)
since 09/26/23

Most Recent Stories

More News
Soligenix (NASDAQ: SNGX) Advances Ricin Vaccine amid Toxin Threat

A recent “Times of India” report spotlighted the danger posed by ricin, a highly toxic plant-derived compound with no known antidote and a history of attempted misuse by extremist actors. Soligenix...

SNGX : 1.3700 (-4.86%)
BMWYY : 29.2000 (+4.58%)
Nutriband (NASDAQ: NTRB) Signs LOI to Explore Quantum-AI Technology Collaboration

Nutriband (NASDAQ: NTRB) announced the signing of a nonbinding letter of intent with the Qvanta Group of Companies to explore potential collaboration involving secure artificial intelligence, advanced...

NTRB : 4.80 (+1.27%)
BMWYY : 29.2000 (+4.58%)
Soligenix (NASDAQ: SNGX) Receives Strong Vote of Confidence from Zacks Report Despite Muted Market Response to Clinical Milestone

When a late-stage clinical trial reports response rates nearly double what researchers expected, yet the stock market barely reacts, seasoned analysts take notice and wonder if investors are missing something...

SNGX : 1.3700 (-4.86%)
BMWYY : 29.2000 (+4.58%)
Soligenix (NASDAQ: SNGX) Reaches Key Enrollment Milestone in Phase 3 Trial with Encouraging Blinded Response Rate

In a pivotal advancement for patients suffering from a rare form of skin cancer, Soligenix (NASDAQ: SNGX) has achieved a critical clinical trial milestone that brings its investigational treatment significantly...

SNGX : 1.3700 (-4.86%)
BMWYY : 29.2000 (+4.58%)
Soligenix (NASDAQ: SNGX) Elevates Advisory Network as Rare Disease Strategy Advance

Soligenix (NASDAQ: SNGX) is entering a new phase of strategic breadth and influence with the appointment of a seasoned, high-level scientific and policy adviser who brings rarefied experience at the intersection...

SNGX : 1.3700 (-4.86%)
BMWYY : 29.2000 (+4.58%)
Soligenix (NASDAQ: SNGX) Strengthens CTCL Program as DMC Flags No Safety Issues

In a key development that underscores the advancing clinical trajectory of its lead therapy, Soligenix (NASDAQ: SNGX) announced that the Data Monitoring Committee (“DMC”) overseeing its confirmatory...

SNGX : 1.3700 (-4.86%)
BMWYY : 29.2000 (+4.58%)
CNS Pharmaceuticals (NASDAQ: CNSP) Targets Glioblastoma with Innovative Therapies, Addressing One of Oncology’s Greatest Unmet Needs

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in novel treatments for primary and metastatic brain cancers is sharpening its focus on glioblastoma multiforme (“GBM”),...

CNSP : 6.17 (-0.48%)
BMWYY : 29.2000 (+4.58%)
Soligenix (NASDAQ: SNGX) Strengthens Financial Foundation to Advance Multiple Value Drivers

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on rare diseases and biodefense programs, continues to fortify its financial position as it advances toward a series of pivotal...

SNGX : 1.3700 (-4.86%)
BMWYY : 29.2000 (+4.58%)
Soligenix (NASDAQ: SNGX) Strengthens Advisory Leadership in Cutaneous T-Cell Lymphoma

Soligenix (NASDAQ: SNGX), a clinical-stage biotechnology company focused on rare diseases and public health solutions, has rejuvenated its U.S. Medical Advisory Board for cutaneous T-cell lymphoma (“CTCL”),...

SNGX : 1.3700 (-4.86%)
BMWYY : 29.2000 (+4.58%)
Nutriband (NASDAQ: NTRB) Receives FDA Meeting Feedback Advancing AVERSA(TM) Fentanyl Toward 505(b)(2) NDA Submission

Nutriband (NASDAQ: NTRB), a developer of prescription transdermal pharmaceutical products, today announced it has received final meeting minutes from its Sept. 18, 2025, virtual meeting with the U.S. Food...

NTRB : 4.80 (+1.27%)
BMWYY : 29.2000 (+4.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bayerische Motoren Werke AG develops, manufactures, and sells automobiles and motorcycles and spare parts and accessories. Bayerische Motoren Werke AG is based in Munich, Germany.

See More

Key Turning Points

3rd Resistance Point 29.5867
2nd Resistance Point 29.4333
1st Resistance Point 29.3167
Last Price 29.2000
1st Support Level 29.0467
2nd Support Level 28.8933
3rd Support Level 28.7767

See More

52-Week High 41.6500
Fibonacci 61.8% 35.3470
Fibonacci 50% 33.4000
Fibonacci 38.2% 31.4530
Last Price 29.2000
52-Week Low 25.1500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar